Related Experiment Video
Updated: Jul 10, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Late-onset vitamin K deficiency bleeding in an extremely preterm infant fed an exclusively human milk-based diet
Vimal Vasu1, Shaveta Mulla2, Atisha Pandya2
1Department of Neonatal Medicine, William Harvey Hospital, Ashford, Kent, UK; School of Biosciences, University of Kent, Canterbury, UK.
Insights
Extremely preterm infants on human milk diets fortified with human milk-based fortifiers may be at risk for vitamin K deficiency bleeding (VKDB). This case highlights the need to assess vitamin K1 intake in these vulnerable infants.
Area of Science:
- Neonatology
- Nutritional Science
- Pediatric Gastroenterology
Background:
- All newborns require phylloquinone (vitamin K1) to prevent vitamin K deficiency bleeding (VKDB).
- Preterm infants, especially those fed exclusively human milk, face risks of late-onset VKDB due to potentially inadequate K1 intake.
- Human milk-based fortifiers (HMF), while beneficial for micronutrients, contain lower K1 levels compared to bovine-derived fortifiers.
Abstract:
All newborns need extra phylloquinone (vitamin K1; K1) to prevent vitamin K deficiency bleeding (VKDB). In preterm babies, the main sources are prophylactic K1 given at birth and parenteral and/or enteral feeding thereafter. Preterm babies are at risk of late-onset VKDB if ongoing K1 supplementation is inadequate. For extremely preterm infants fed an exclusive human milk diet, the low K1 content of human milk may predispose them to vitamin K deficiency. Human milk fortification with either bovine milk-derived fortifier or human milk-based fortifier (HMF) made from pooled donor milk is a widely used strategy to improve the micronutrient and growth status of preterm infants. However, the K1 content of HMF is markedly lower than that of bovine-based preparations. We present an unusual case of late-onset VKDB in an extremely preterm infant who received an exclusive human milk diet and HMF and quantify total K1 intake prior to the bleeding.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins

